NEW YORK (GenomeWeb News) – Caliper Life Sciences reported after the close of the market on Monday that its third-quarter revenues fell 7 percent as its license fees and contract revenues took an expected sharp downturn year over year.
 
Caliper also said that it completed the sale of two non-core businesses for close to $21 million.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Women with breast or ovarian cancer living in medically underserved regions of the US are less likely to get recommended BRCA1 or BRCA2 genetic testing, according to a new study.

Three immunology researchers are to receive this year's Albany Medical Center Prize in Medicine and Biomedical Research, the Albany Times-Union reports.

In Genome Research this week: clonal evolution analysis of acute myeloid leukemia, computational pipeline to examine relationships between bacterial pathogens, and more.

Elephants may have "re-animated" a pseudogene to help stave off cancer, according to the New York Times.